Treatment Errors

Latest Issue of OR Manager
July 2020
Home Safety/Quality > Patient Safety > Treatment Errors

Lancet, NEJM retract COVID-19 treatment studies

Editor's Note The Lancet and New England Journal of Medicine (NEJM) have both retracted COVID-19 treatment studies because of concerns about the validity of the data and how the research was conducted by Chicago-based Surgisphere Corp, the June 4 Medscape Medical News reports. Authors of the Lancet study, which was…

Read More

By: Judy Mathias
June 8, 2020
Share

COVID-19: Randomized, double-blind, placebo-controlled, multicenter trial of remdesivir

Editor's Note In this randomized, double-blind, placebo-controlled, multicenter trial of remdesivir for the treatment of COVID-19, remdesivir was not associated with statistically significant clinical benefits. For the analysis, 237 patients were randomly assigned to either a treatment group with remdesivir (158 patients) or placebo (79 patients). Remdesivir use was not…

Read More

By: Judy Mathias
April 30, 2020
Share

Royal Philips issues urgent safety alert for fluoroscopy system

Editor's Note Royal Philips has issued an urgent field safety notice for its CombiDiagnost R90 GCF fluoroscopy system, the January 10 MassDevice reports. When the tilting feature is used, the device could be locked in a “Table Up/Down” state, an issue that could result in the entry of contrast agent…

Read More

By: Judy Mathias
January 14, 2020
Share

Sponsored Message

Development of surgery-specific second victim peer support program

Editor's Note In this study, researchers at the Massachusetts General Hospital, designed, implemented, and assessed the effect of the first surgery-specific peer support program in the US. The program uses five steps: creation of a conceptual framework choice of peer supporters training of peer supporters multifaceted identification of major adverse…

Read More

By: Judy Mathias
December 17, 2019
Share

Editorial

Projections for healthcare industry trends in 2020 started to proliferate near the end of 2019 as attention turned to the new year. Reflecting on the Institute of Medicine’s (IOM) landmark 1999 report, “To Err Is Human: Building a Safer Health System,” some healthcare leaders said the report has raised awareness…

Read More

By: OR Manager
December 17, 2019
Share

FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System

Editor's Note The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious. The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five…

Read More

By: Judy Mathias
November 14, 2019
Share

Sponsored Message

Cholecystectomy tied to better outcomes when performed soon after admission

Editor's Note Delaying a cholecystectomy for acute cholecystitis more than 3 days after admission increased the rate of complications, hospital readmissions, and lengthened hospital stays, in this study presented October 30 at the American College of Surgeons Clinical Congress 2019 in San Francisco. Using 2012 to 2016 ACS National Surgical…

Read More

By: Judy Mathias
November 4, 2019
Share

Laminated posters, badge buddies on NPSGs available from Joint Commission

Editor's Note The Joint Commission announced on October 23 that laminated posters and badge buddies on the 2020 National Patient Safety Goals (NPSGs) for hospitals are now available for purchase. Areas covered by the NPSGs include: Patient identification Infection prevention Patient safety risks Safe surgery. The posters and badge buddies…

Read More

By: Judy Mathias
October 24, 2019
Share

ECRI Institute: Diagnostic testing, medication events pose biggest safety risks to ambulatory care patients

Editor's Note New research from the ECRI Institute finds that diagnostic tests and medication events are the most frequent safety risks patients face in ambulatory care. ECRI Institute’s “Deep Dive: Safe Ambulatory Care, Strategies for Patient Safety & Risk Reduction” identifies solutions for five types of safety challenges in ambulatory…

Read More

By: Judy Mathias
October 23, 2019
Share

Proactive steps paramount for greater surgical stapler safety

Internal surgical staplers made headline news in 2019. Reports discussed the little-known US Food and Drug Administration database housing tens of thousands of stapler-related problem reports and covered the agency’s recent proposal to reclassify staplers as Class II devices, instead of the more lightly regulated Class I. ECRI Institute named…

Read More

By: OR Manager
October 21, 2019
Share

Get OR Manager Updates

Sign Up Now
Video Spotlight
OR Manager Jobs
Live chat by BoldChat